DNA Polymerase θ: A Cancer Drug Target with Reverse Transcriptase Activity.
DNA Polymerase θ: A Cancer Drug Target with Reverse Transcriptase Activity.
复制标题
DOI:
10.3390/genes12081146
复制
发表时间:
2021-07-27
期刊:
影响因子:
3.5
通讯作者:
Pomerantz RT
中科院分区:
文献类型:
--
作者:
Chen XS;Pomerantz RT
The emergence of precision medicine from the development of Poly (ADP-ribose) polymerase (PARP) inhibitors that preferentially kill cells defective in homologous recombination has sparked wide interest in identifying and characterizing additional DNA repair enzymes that are synthetic lethal with HR factors. DNA polymerase theta (Polθ) is a validated anti-cancer drug target that is synthetic lethal with HR factors and other DNA repair proteins and confers cellular resistance to various genotoxic cancer therapies. Since its initial characterization as a helicase-polymerase fusion protein in 2003, many exciting and unexpected activities of Polθ in microhomology-mediated end-joining (MMEJ) and translesion synthesis (TLS) have been discovered. Here, we provide a short review of Polθ‘s DNA repair activities and its potential as a drug target and highlight a recent report that reveals Polθ as a naturally occurring reverse transcriptase (RT) in mammalian cells.
登录
查看更多内容
影响因子:
8.8
作者:
Chandramouly G;Liao S;Rusanov T;Borisonnik N;Calbert ML;Kent T;Sullivan-Reed K;Vekariya U;Kashkina E;Skorski T;Yan H;Pomerantz RT
通讯作者:
Pomerantz RT
影响因子:
16.6
作者:
Chim N;Meza RA;Trinh AM;Yang K;Chaput JC
通讯作者:
Chaput JC
影响因子:
4.5
作者:
Carvajal-Garcia J;Crown KN;Ramsden DA;Sekelsky J
通讯作者:
Sekelsky J
影响因子:
16.8
作者:
Kent, Tatiana;Chandramouly, Gurushankar;McDevitt, Shane Michael;Ozdemir, Ahmet Y.;Pomerantz, Richard T.
通讯作者:
Pomerantz, Richard T.
影响因子:
158.5
作者:
Grein, J.;Ohmagari, N.;Flanigan, T.
通讯作者:
Flanigan, T.